Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease, Hematology, Hematology |
| Therapuetic Areas: | Hematology, Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/3/2019 |
| Start Date: | November 17, 2014 |
| End Date: | January 22, 2018 |
Open Label, Adaptive Design, Ascending, Multiple-Dose Study to Evaluate Safety and Efficacy of BMS-986004 in Adult Subjects With Primary Immune Thrombocytopenia (ITP)
The purpose of this study is to assess the safety and tolerability of BMS-986004 when
administered in subjects with ITP.
administered in subjects with ITP.
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com
Inclusion Criteria:
- ≥18 years old, diagnosed with persistent or chronic ITP
Exclusion Criteria:
- Secondary immune thrombocytopenia
- Drug induced thrombocytopenia
We found this trial at
7
sites
3800 Reservoir Rd NW
Washington, District of Columbia 20007
Washington, District of Columbia 20007
(202) 687-7695
Georgetown University Medical Center Georgetown University Medical Center is committed to excellence in research, education...
Click here to add this to my saved trials
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Los Angeles, California 90033
Phone: 323-865-3943
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials